Does CABOZANTINIB S-MALATE Cause Intestinal obstruction? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Intestinal obstruction have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.1% of all adverse event reports for CABOZANTINIB S-MALATE.
48
Reports of Intestinal obstruction with CABOZANTINIB S-MALATE
0.1%
of all CABOZANTINIB S-MALATE reports
9
Deaths
34
Hospitalizations
How Dangerous Is Intestinal obstruction From CABOZANTINIB S-MALATE?
Of the 48 reports, 9 (18.8%) resulted in death, 34 (70.8%) required hospitalization, and 6 (12.5%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 48 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Intestinal obstruction Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE